The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Renal denervation in patients with chronic kidney disease: current evidence and future perspectives
Open accessAbstract
Supported by several high-quality randomized controlled trials and registry analyses, catheter-based renal denervation is becoming an important adjunctive treatment modality for the safe and efficacious treatment of hypertension besides lifestyle modifications and antihypertensive medication. Renal denervation is of particular interest to nephrologists as the intervention may provide additional benefits to hypertensive people with chronic kidney disease (CKD), a condition typically characterized by sympathetic hyperactivity. A growing body of clinical evidence supports the safety and efficacy of renal denervation in this difficult-to-control population. In addition, preclinical and clinical research works indicate potential nephroprotective effects in CKD patients. The current review examines recent research on renal denervation with a focus on renal disease and assesses the latest findings and their implications from a nephrologist's perspective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1: Effect of bilateral nephrectomy on SNS activity in renal transplant patients. From Hausberg et al [12]. MSNA, muscle sympathetic activity; CVR, calf vascular resistance; n.s., not significant.](https://figures.cochat.ai/paper-figures/ebf935d0df6749fe90c2ea67d30ad069/renal-denervation-in-patients-with-chronic-kidney-disease-current-evidence-and-figure-1.jpg)

![FIGURE 3: Changes from baseline with renal denervation or sham up to 36 months in the randomized, sham-controlled SPYRAL-ON MED study. Medication changes were allowed after end of primary follow-up at 6 months and patients were unblinded to randomization status at 12 months. Adapted from Mahfoud et al [27].](https://figures.cochat.ai/paper-figures/afc12b7691ca453993712996b741cff9/renal-denervation-in-patients-with-chronic-kidney-disease-current-evidence-and-figure-3.jpg)
![FIGURE 4: Muscle sympathetic nerve activity (MSNA) expressed as burst frequency (bs/min; blue bars; left-hand scale) and burst incidence (bs/100 heartbeats; green bars; right-hand scale) in patients and healthy individuals grouped according to progressively more severe degrees of renal dysfunction. Adapted from Grassi et al [43].](https://figures.cochat.ai/paper-figures/718d520b7d7942d49274119fde9a8c14/renal-denervation-in-patients-with-chronic-kidney-disease-current-evidence-and-figure-4.jpg)
![FIGURE 5: Mean basal total urinary NOx (nitrate + nitrite) excretion (V) in normotensive (control) and hypertensive sheep with CKD 2 and 30 months after renal denervation or sham procedures, respectively. Lines indicate standard error. *P < .05 comparing sham groups at follow-up. ##P < .05, ####P < .0001 comparing sham and treated groups at follow-up. From Singh et al [58].](https://figures.cochat.ai/paper-figures/0425e9ce69d2475d9ef8ec20b2f7a4bd/renal-denervation-in-patients-with-chronic-kidney-disease-current-evidence-and-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As large clinical trials of RDN have excluded patients with GFR <45 ml/min/1.73 m2 (ref. 119), the efficacy of this approach in patients with kidney failure is difficult to discern.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citationBikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M., Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30045-3 · Cited by 6,648
A Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402670 · Cited by 2,186
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132 · cited 2×
“This increase in GFR was accompanied by a sustained reduction in MAP; conversely there was a continual increase in MAP with time in sham-treated sheep.”
BackgroundKandzari, D. E., Böhm, M., Mahfoud, F., Townsend, R. R., Weber, M. A., Pocock, S., Tsioufis, K., Tousoulis, D., Choi, J. W., East, C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30951-6 · Cited by 793
Self-citationTownsend, R. R., Mahfoud, F., Kandzari, D. E., Kario, K., Pocock, S., Weber, M. A., Ewen, S., Tsioufis, K., Tousoulis, D., Sharp, A. S. P., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32281-x · Cited by 752
Self-citationAzizi, M., Schmieder, R. E., Mahfoud, F., Weber, M. A., Daemen, J., Davies, J., Basile, J., Kirtane, A. J., Wang, Y., Lobo, M. D., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31082-1 · Cited by 740
Self-citationBöhm, M., Kario, K., Kandzari, D. E., Mahfoud, F., Weber, M. A., Schmieder, R. E., Tsioufis, K., Pocock, S., Konstantinidis, D., Choi, J. W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30554-7 · Cited by 606
Self-citationPredictors of blood pressure response in the SYMPLICITY HTN-3 trial
Kandzari, D. E., Bhatt, D. L., Brar, S., Devireddy, C. M., Esler, M., Fahy, M., Flack, J. M., Katzen, B. T., Lea, J., Lee, D. P., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu441 · Cited by 546 · cited 1×
“The latter two confounders would explain the substantial BP reductions in the sham group [17, 18].”
Background
Cited by
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citationHypertension in chronic kidney disease—treatment standard 2023
Georgianos, P. I., & Agarwal, R. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad118 · Cited by 114
Diagnosis and management of resistant hypertension
Schiffrin, E. L., & Fisher, N. D. L. (2024) · BMJ · doi:10.1136/bmj-2023-079108 · Cited by 80
Sympathetic Nervous System and Atherosclerosis
Wang, Y., Anesi, J., Maier, M. C., Myers, M. A., Oqueli, E., Sobey, C. G., Drummond, G. R., & Denton, K. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713132 · Cited by 54
Renal nerves in physiology, pathophysiology and interoception
Evans, L. C., Dayton, A., & Osborn, J. W. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00893-3 · Cited by 46
“119), the efficacy of this approach in patients with kidney failure is difficult to discern.”
Metadata
- Authors
- Schmieder, R. E.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Corresponding author
- Schmieder, Roland E
- ORCID
- Schmieder, Roland E
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-05-25
- Volume
- 38
- Issue
- 5
- Pages
- 1089-1096
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- PMC
- PMC10157753
- OpenAlex
- W4281568867
- Cited by
- 39
- References
- 65
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 6 · 2023: 10 · 2022: 1
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nephrology Dialysis Transplantation (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Medtronic
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal and Vascular Pathologies
- Keywords
- renal denervation, chronic kidney disease, hypertension, catheter ablation, sympathetic hyperactivity, renal protection, adjunctive therapy, antihypertensive therapy
- MeSH terms
- Antihypertensive Agents, Blood Pressure, Denervation, Humans, Hypertension, Kidney, Sympathectomy, Treatment Outcome, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Renal denervation in patients with chronic kidney disease: current evidence and future perspectives. https://app.cochat.ai/papers/10.1093/ndt/gfac189
- The paper
- Schmieder, R. E. (2023). Renal denervation in patients with chronic kidney disease: current evidence and future perspectives. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfac189
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.